Market Snapshot

BSE Sensex: 80951.99 -0.79%
BSE 500: 35542.53 -0.56%
BSE 200: 11171.96 -0.65%
BSE 100: 25795.88 -0.71%
BSE MidCap: 44638.43 -0.33%
BSE SmallCap: 51289.32 0.17%
BSE BANKEX: 62348.33 -0.27%
BSE IT: 36615.34 -1.09%
Nifty 50: 24609.7 -0.82%
Nifty 500: 22595 -0.60%
Nifty 200: 13698.55 -0.70%
Nifty 100: 25221.9 -0.74%
Nifty Midcap 100: 56324.85 -0.52%
Nifty Small 100: 17503.1 -0.26%
Nifty IT: 37050.1 -1.31%
Nifty PSU Bank: 6667.95 -0.58%

News:

Mehai Tech Q4 PAT soars to Rs ...
Subros Q4 PAT climbs 52% YoY o...
Interglobe Aviation Q4 PAT ris...
BSE drops as SEBI mulls Tuesda...
Deepak Fertilisers records ove...

Syncom Formulations (India) Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

22 May 2025 | 04:14 PM

19.71

-0.30 (-1.50%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

49.32%

Return (1Y)

Beaten Nifty 50 by 39.18%
More Volatile

3.53%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.54%
Not so consistent

6/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

News & Announcements

Syncom Formulations (India) consolidated net profit rises 139.05% in the March 2025 quarter

2 days ago

Syncom Formulations (India) schedules board meeting
8 days ago

Syncom Formulations (India) schedules board meeting

14 - May - 2025 12:00 | 8 days ago

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 19 May 2025.
Powered by Capital Market - Live News
Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter
100 days ago

Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter

11 - Feb - 2025 12:00 | 100 days ago

Net profit of Syncom Formulations (India) rose 85.71% to Rs 13.00 crore in the quarter ended December 2024 as against Rs 7.00 crore during the previous quarter ended December 2023. Sales rose 95.78% to Rs 127.53 crore in the quarter ended December 2024 as against Rs 65.14 crore during the previous quarter ended December 2023.
Particulars Quarter Ended
Dec. 2024 Dec. 2023 % Var.
Sales 127.53 65.14 96
OPM % 11.55 11.28 -
PBDT 18.57 10.83 71
PBT 17.26 9.38 84
NP 13.00 7.00 86
Powered by Capital Market - Live News
Syncom Formulations (India) consolidated net profit rises 70.66% in the September 2024 quarter
191 days ago

Syncom Formulations (India) consolidated net profit rises 70.66% in the September 2024 quarter

12 - Nov - 2024 12:00 | 191 days ago

Net profit of Syncom Formulations (India) rose 70.66% to Rs 11.11 crore in the quarter ended September 2024 as against Rs 6.51 crore during the previous quarter ended September 2023. Sales rose 60.26% to Rs 102.31 crore in the quarter ended September 2024 as against Rs 63.84 crore during the previous quarter ended September 2023.
Particulars Quarter Ended
Sep. 2024 Sep. 2023 % Var.
Sales 102.31 63.84 60
OPM % 11.89 10.03 -
PBDT 16.15 9.33 73
PBT 14.85 8.45 76
NP 11.11 6.51 71
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Syncom Formulations (India) Ltd has decreased by -17.91% since past 3 Months
FII shareholding in Syncom Formulations (India) Ltd has increased by 35.93% since past 1 Year
MF shareholding in Syncom Formulations (India) Ltd has increased by 157.14% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	148.88	74.57	100	465.01	263.39	77
OPM %	11.92	12.63	-	11.64	11.25	-
PBDT	24.58	11.33	117	70.70	38.70	83
PBT	23.29	10.03	132	65.50	33.97	93
NP	17.69	7.40	139	49.43	25.31	95

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	127.53	65.14	96
OPM %	11.55	11.28	-
PBDT	18.57	10.83	71
PBT	17.26	9.38	84
NP	13.00	7.00	86

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	102.31	63.84	60
OPM %	11.89	10.03	-
PBDT	16.15	9.33	73
PBT	14.85	8.45	76
NP	11.11	6.51	71

General Notifications

My Notifications

Research Notifications

Syncom Formulations (India) Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

19.71 -0.30 (-1.50%)

News & Announcements

Price vs Volume

Stock Trivia

Syncom Formulations (India) Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

19.71

-0.30 (-1.50%)